881
Views
2
CrossRef citations to date
0
Altmetric
Review

Cognitive impairment in chronic obstructive pulmonary disease: disease burden, determinants and possible future interventions

ORCID Icon, , &
Pages 1061-1074 | Received 30 May 2018, Accepted 04 Oct 2018, Published online: 14 Oct 2018

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report). Agusti A, Vogelmeier C, editors.2018.
  • Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475.
  • Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913–922.
  • Cleutjens FA, Janssen DJ, Ponds RW, et al. COgnitive-pulmonary disease. Biomed Res Int. 2014;697825.
  • Lezak MD, Howieson DB, Bigler ED, et al. Neuropsychological assessment. 5th. New York, NY: Oxford University Press; 2012.
  • Franz EA, Gillett G. John Hughlings Jackson’s evolutionary neurology: a unifying framework for cognitive neuroscience. Brain. 2011;134(10):3114–3120.
  • Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135–168.
  • Kolb B, Whishaw IQ. An introduction to brain and behavior. 3rd ed. New York, NY: Worth Publishers; 2011.
  • Petersen RC. Mild cognitive impairment. Continuum. 2016;22(2):404–418.
  • Belleville S, Fouquet C, Hudon C, et al. Neuropsychological measures that predict progression from mild cognitive impairment to Alzheimer’s type dementia in older adults: a systematic review and meta-analysis. Neuropsychol Rev. 2017;27(4):328–353.
  • Ouellette DR, Lavoie KL. Recognition, diagnosis and treatment of cognitive and psychiatric disorders in patients with COPD. Int J COPD. 2017;12:639–650.
  • Zhang H, Wang X, Lin J, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study. BMJ Open. 2012;2:e000844.
  • Schou L, Ostergaard B, Rasmussen LS, et al. Cognitive dysfunction in patients with chronic obstructive pulmonary disease - a systematic review. Respir Med. 2012;106:1071–1081.
  • Zhang J, Chen J, Yu Q, et al. Alteration of spontaneous brain activity in COPD patients. Int J COPD. 2016;11:1713–1719.
  • Zhang H, Wang X, Lin J, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. Am J Neuroradiology. 2013;34(2):334–339.
  • Andrianopoulos V, Gloeckl R, Vogiatzis I, et al. Cognitive impairment in COPD: should cognitive evaluation be part of respiratory assessment? Breathe. 2017;13(1):e1–e9.
  • Yohannes AM, Chen W, Moga AM, et al. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. JAMDA. 2017;18:451.e1–451.e11.
  • Cleutjens FA, Franssen FM, Spruit MA, et al. Domain-specific cognitive impairment in patients with COPD and control subjects. Int J COPD. 2016;12:1–11.
  • Cleutjens FA, Spruit MA, Ponds RW, et al. Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2018;15(2):91–102.
  • Pierobon A, Bottelli ES, Ranzini L, et al. COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation. Int J COPD. 2017;12:2059–2067.
  • Roncero C, Campuzano AI, Quintano JA, et al. Cognitive status among patients with chronic obstructive pulmonary disease. Int J COPD. 2016;11:543–551.
  • Dodd JW, Charlton RA, Van den Broek MD, et al. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest. 2013;144:119–127.
  • Fekri MS, Hashemi-Bajgani S-M, Naghibzadeh-Tahami A, et al. Cognitive impairment among patients with chronic obstructive pulmonary disease compared to normal individuals. Tanaffos. 2017;16(1):34–39.
  • Jolles J, Van Boxtel MPJ, Ponds RW, et al. The Maastricht Aging Study (MAAS): the longitudinal perspective of cognitive aging. Tijdschr Gerontol Geriatr. 1998;29(3):120–129.
  • López-Torres I, Valenza MC, Torres-Sánchez I, et al. Changes in cognitive status in COPD patients across clinical stages. COPD. 2016;13(3):327–332.
  • Rusanen M, Ngandu T, Laatikainen T, et al. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013;10:549–555.
  • Park SK. Trajectories of change in cognitive function in people with COPD. J Clin Nurs. 2018;27:1529–1542.
  • Korfias S, Stranjalis G, Papadimitrou A, et al. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem. 2006;13(30):3719–3731.
  • Esser RW, Stoeckel MC, Kirsten A, et al. Structural brain changes in patients with COPD. Chest. 2016;149(2):426–434.
  • Spilling CA, Jones PW, Dodd JW, et al. White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not. BMC Pulm Med. 2017;17:92.
  • Dodd JW, Chung AW, Van den Broek MD, et al. Brain structure and function in chronic obstructive pulmonary disease - a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186(3):240–245.
  • Ryu C-W, Jahng G-H, Choi CW, et al. Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRI. J Chronic Obstructive Pulm Dis. 2013;10:357–366.
  • Cleutjens FA, Ponds RW, Spruit MA, et al. The relationship between cerebral small vessel disease, hippocampal volume and cognitive functioning in patients with COPD: an MRI study. Front Aging Neurosci. 2017;9:88.
  • Chen J, Lin I-T, Zhang H, et al. Reduced cortical thickness, surface area in patients with chronic obstructive pulmonary disease: a surface-based morphometry and neuropsychological study. Brain Imaging Behav. 2016;10:464–476.
  • Barbey AK, Koenigs M, Grafman J. Dorsolateral prefrontal contributions to human working memory. Cortex. 2013;49:1195–1205.
  • Wang C, Ding Y, Shen B, et al. Altered gray matter volume in stable chronic obstructive pulmonary disease with subclinical cognitive impairment: an exploratory study. Neurotox Res. 2017;31(4):453–463.
  • Lövblad KO, Schaller K, Vargas MI. The fornix and limbic system. Semin Ultrasound CT MR. 2014;35(5):459–473.
  • Sachdev PS, Anstey KJ, Parslow RA, et al. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord. 2006;21:300–308.
  • Taki Y, Kinomura S, Ebihara S, et al. Correlation between pulmonary function and brain volume in healthy elderly subjects. Neuroradiology. 2013;55(6):689–695.
  • Poulose SM, Miller MG, Scott T, et al. Nutritional factors affecting adult neurogenesis and cognitive function. Adv Nutr. 2017;8:804–811.
  • Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res. 2013;14:140.
  • Borson S, Scanlan J, Friedman S, et al. Modeling the impact of COPD on the brain. Int J COPD. 2008;3(3):429–434.
  • Fox MD, Snyder AZ, Vincent JL, et al. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Pnas. 2005;102(27):9673–9678.
  • Hu X, Wang H, Tu Y, et al. Alterations of the default mode network and cognitive impairments in patients with chronic obstructive pulmonary disease. Int J COPD. 2018;13:519–528.
  • Leung JM, Sin DD. Chronic obstructive pulmonary disease and stroke: strange bedfellows. Am J Respir Crit Care Med. 2016;193(3):227–228.
  • Portegies MLP, Lahousse L, Joos GF, et al. Chronic obstructive pulmonary disease and the risk of stroke: the Rotterdam study. Am J Respir Crit Care Med. 2016;193(3):251–258.
  • Soderholm M, Inghammar M, Hedblad B, et al. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159–168.
  • Morgan AD, Sharma C, Rothnie KJ, et al. Chronic obstructive pulmonary disease and the risk of stroke. Ann Am Thorac Soc. 2017;14(5):754–765.
  • Kim YR, Hwang IC, Lee YJ, et al. Stroke risk among patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clinics. 2018;73:e177.
  • Effing TW, Vercoulen JH, Bourbeau J, et al. Definition of a COPD self-management intervention: international expert group consensus. Eur Respir J. 2016;48(1):46–54.
  • Baird C, Lovell J, Johnson M, et al. The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: a systematic review. Respir Med. 2017;129:130–139.
  • Dulohery MM, Schroeder DR, Benzo R. Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life? Int J COPD. 2015;10:1883–1889.
  • Benzo R, Kirsch JL, Dulohery MM, et al. Emotional intelligence: a novel outcome associated with wellbeing and self-management in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(1):10–16.
  • Meek P, Lareau SC, Anderson D. Memory for symptoms in COPD patients: how accurate are their reports? Eur Respir J. 2001;18(3):474–481.
  • Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J. 2002;78:37–39.
  • Brega AG, Grigsby J, Kooken R, et al. The impact of executive cognitive functioning on rates of smoking cessation in the San Luis Valley health and aging study. Age Ageing. 2008;37(5):521–525.
  • Fox AT, Martin LE, Bruce J, et al. Executive function fails to predict smoking outcomes in a clinical trial to motivate smokers to quit. Drug Alcohol Depend. 2017;175:227–231.
  • Cohen-Mansfield J. Predictors of smoking cessation in old-old age. Nicotine Tob Res. 2016;18(7):1675–1679.
  • Ozyemisci-Taskiran O, Bozkurt SO, Kokturk N, et al. Is there any association between cognitive status and functional capacity during exacerbation of chronic obstructive pulmonary disease? Chron Respir Dis. 2015;12(3):247–255.
  • Yazar EE, Aydin S, Gunluoglu G, et al. Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2018;15(3):306–314
  • Cleutjens FAHM, Spruit MA, Ponds RWHM, et al. The impact of cognitive impairment on efficacy of pulmonary rehabilitation in patients with COPD. JAMDA. 2017;18(5):420–426.
  • Schure MB, Borson S, Nguyen HQ, et al. Associations of cognition with physical functioning and health-related quality of life among COPD patients. Respir Med. 2016;114:46–52.
  • Martinez CH, Richardson CR, Han MK, et al. Chronic obstructive pulmonary disease, cognitive impairment, and development of disability: the Health and Retirement study. Ann Am Thorac Soc. 2014;11(9):1362–1370.
  • Chang SS, Chen S, McAvay GJ, et al. Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults. J Am Geriatr Soc. 2012;60(10):1839–1846.
  • Dodd JW, Novotny P, Sciurba FC, et al. Executive function, survival, and hospitalization in chronic obstructive pulmonary disease: a longitudinal analysis of the National Emphysema Treatment Trial (NETT). Ann Am Thorac Soc. 2015;12(10):1473–1481.
  • Antonelli Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD. Chest. 2006;130(6):1687–1694.
  • Yohannes AM, Raue PJ, Kanellopoulos D, et al. Predictors of all-cause mortality in patients with severe COPD and major depression admitted to a rehabilitation hospital. Chest. 2016;149(2):467–473.
  • Alexandre F, Heraud N, Varray A. Is nocturnal desaturation a trigger for neuronal damage in chronic obstructive pulmonary disease? Med Hypotheses. 2015;84:25–30.
  • Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220.
  • Antonelli Incalzi R, Marra C, Giordaon A, et al. Cognitive impairment in chronic obstructive pulmonary disease - a neuropsychological and spect study. J Neurol. 2003;250(3):325–332.
  • Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med. 2006;20(2):99–106.
  • Teppema LJ, Dahan A. The ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis. Physiol Rev. 2010;90(2):675–754.
  • Sicard KM, Duong TQ. Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. Neuroimage. 2005;25(3):850–858.
  • Sumiyoshi A, Suzuki H, Shimokawa H, et al. Neurovascular uncoupling under mild hypoxic hypoxia: an EEG-fMRI study in rats. J Cereb Blood Flow Metab. 2012;32(10):1853–1858.
  • Marshall O, Uh J, Lurie D, et al. The influence of mild carbon dioxide on brain functional homotopy using resting-state fMRI. Hum Brain Mapp. 2015;36(10):3912–3921.
  • Hartmann SE, Pialoux V, Leigh R, et al. Decreased cerebrovascular response to CO2 in post-menopausal females with COPD: role of oxidative stress. Eur Respir J. 2012;40:1354–1361.
  • Nguyen JC, Killcross AS, Jenkins TA. Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci. 2014;8:375.
  • Solas M, Milagro FI, Ramirez MJ, et al. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions. Curr Opin Pharmacol. 2017;37:87–92.
  • Siervo M, Harrison SL, Jagger C, et al. Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis. J Alzheimer’s Disease. 2014;41(1):151–161.
  • Panza F, Frisardi V, Capurso C, et al. Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimer’s Disease. 2010;21(3):691–724.
  • Schram MT, Euser SM, De Craen AJ, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007;55(5):708–716.
  • Crisan AF, Oancea C, Timar B, et al. Cognitive impairment in chronic obstructive pulmonary disease. PLoS One. 2014;9(7):e102468.
  • Pfistermeister B, Tümena T, Gassmann K-G, et al. Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients. PLoS ONE. 2017;12(2):e0171353.
  • Jessen F, Kaduszkiewicz H, Daerr M, et al. Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci. 2010;260(Suppl 2):S111–S115.
  • Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–407.
  • Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477–1483.
  • Heredia JL. Tiotropium bromide: an update. Open Respir Med J. 2009;3:43–52.
  • Joels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci. 2006;27(5):244–250.
  • Wolkowitz OM, Lupien SJ, Bigler ED. The “steroid dementia syndrome”: a possible model of human glucocorticoid neurotoxicity. Neurocase. 2007;13(3):189–200.
  • Cipriani G, Picchi L, Vedovello M, et al. Reversible dementia from corticosteroid therapy. Clin Geriatr. 2012;20(7):3841.
  • Walters JA, Tan DJ, White CJ, et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;3:CD006897.
  • Wolkowitz OM, Lupien SJ, Bigler ED. The “steroid dementia syndrome”: a possible model of human glucocorticoid neurotoxicity. Neurocase. 2007;13:189–200.
  • Zhang X, Cai X, Shi X, et al. Chronic obstructive pulmonary disease as a risk factor for cognitive dysfunction: a meta-analysis of current studies. J Alzheimer’s Disease. 2016;52:101–111.
  • Tulek B, Atalay NB, Yildirim G, et al. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Respirology. 2014;19(6):873–880.
  • Wedzicha JA, Seemungal TAR. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796.
  • Cebron Lipovec N, Beijers RJ, Van den Borst B, et al. The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD. 2016;13(3):399–406.
  • Andreou G, Vlachos F, Makanikas K. Effects of chronic obstructive pulmonary disease and obstructive sleep apnea on cognitive functions: evidence for a common nature. Sleep Disord. 2014;2014:768210.
  • Daulatzai MA. Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius. Sleep Disord. 2012;2012:251096.
  • Olaithe M, Bucks RS, Hillman DR, et al. Cognitive deficits in obstructive sleep apnea: insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation. Sleep Med Rev. 2018;38:39–49.
  • Aras YG, Tunc A, Gungen BD, et al. The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease. Cogn Neurodyn. 2017;11(6):565–571.
  • Fritzsche A, Watz H, Magnussen H, et al. Cognitive biases in patients with chronic obstructive pulmonary disease and depression - a pilot study. Br J Health Psychol. 2013;18:827–843.
  • Viscogliosi G, Donfrancesco C, Palmieri L, et al. The metabolic syndrome and 10-year cognitive and functional decline in very old men - a population-based study. Arch Gerontol Geriatr. 2017;70:62–66.
  • Alfaro FJ, Lioutas VA, Pimentel DA, et al. Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities. J Neurol. 2016;263(12):2505–2514.
  • Assuncao N, Sudo FK, Drummond C, et al. Metabolic syndrome and cognitive decline in the elderly: a systematic review. PLoS One. 2018;13(3):e0194990.
  • Overman MJ, Pendleton N, O’Neill TW, et al. Glycemia but not the metabolic syndrome is associated with cognitive decline: findings from the European male ageing study. Am J Geriatr Psychiatry. 2017;25(6):662–671.
  • Grant I, Heaton RK, McSweeny AJ, et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470–1476.
  • Ling J, Heffernan T. The cognitive deficits associated with second-hand smoking. Front Psychiatry. 2016;7:46.
  • Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychological Rev. 2007;17:259–273.
  • Waisman Campos M, Serebrisky D, Castaldelli-Maia JM. Smoking and cognition. Curr Drug Abuse Rev. 2016;9:1–4.
  • Qiao D, Seidler FJ, Slotkin TA. Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicol Appl Pharmacol. 2005;206(1):17–26.
  • Zhang X, Salmeron BJ, Ross TJ, et al. Anatomical differences and network characteristics underlying smoking cue reactivity. NeuroImage. 2011;54(1):131–141.
  • Zhang X, Salmeron BJ, Ross TJ, et al. Factors underlying prefrontal and insula structural alterations in smokers. NeuroImage. 2011;54(1):42–48.
  • Yu R, Zhao L, Lu L. Regional grey and white matter changes in heavy male smokers. PLoS One. 2011;6(11):e27440.
  • Dal Negro RW, Bonadiman L, Tognella S, et al. Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Int J COPD. 2014;26(9):675–683.
  • Torres-Sanchez I, Rodriguez-Alzueta E, Cabrera-Martox I, et al. Cognitive impairment in COPD: a systematic review. Jornal Brasileiro de Pneumologia. 2015;41(2):182–190.
  • Lai JS, Hiles S, Bisquera A, et al. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr. 2014;99(1):181–197.
  • Abbatecola AM, Russo M, Barbieri M. Dietary patterns and cognition in older persons. Curr Opin Clin Nutr Metab Care. 2018;21(1):10–13.
  • Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771–785.
  • Radley J, Morilak D, Viau V, et al. Chronic stress and brain plasticity: mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders. Neurosci Biobehav Rev. 2015;58:79–91.
  • Marin M-F, Lord C, Andrews J, et al. Chronic stress, cognitive functioning and mental health. Neurobiol Learn Mem. 2011;96(4):583–595.
  • Sandi C. Stress and cognition. Wiley Interdiscip Rev Cogn Sci. 2013;4(3):245–261.
  • Allen AP, Dinan TG, Clarke G, et al. A psychology of the human brain-gut-microbiome axis. Soc Personal Psychol Compass. 2017;11(4):e12309.
  • Martin CR, Preedy VR, Abbatecola AM, editors. Diet and nutrition in dementia and cognitive decline. London, England: Academic Press; 2015.
  • Smyth A, Dehghan M, O’Donnell M, et al. Healthy eating and reduced risk of cognitive decline: a cohort from 40 countries. Neurology. 2015;84(22):2258–2265.
  • Collins PF, Elia M, Kurukulaaratchy RJ, et al. The influence of deprivation on malnutrition risk in outpatients with chronic obstructive pulmonary disease (COPD). Clin Nutr. 2018;37(1):144–148.
  • Horadagoda C, Dinihan T, Roberts M, et al. Body composition and micronutrient deficiencies in patients with an acute exacerbation of chronic obstructive pulmonary disease. Intern Med J. 2017;47(9):1057–1063.
  • Van de Bool C, Mattijssen-Verdonschot C, Van Melick PP, et al. Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation. Eur J Clin Nutr. 2014;68(2):159–165.
  • Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health. 2014;14:510.
  • Tudor-Locke C, Craig CL, Aoyagi Y, et al. How many steps/day are enough? For older adults and special populations. Int J Behav Nutr Phys Activity. 2011;8:80.
  • Kobayashi Y, Takahashi Y, Seki T, et al. Decreased physical activity associated with executive dysfunction correlates with cognitive impairment among older adults in the community: a retrospective analysis from the Kurihara project. Dement Geriatr Cogn Dis Extra. 2016;6(2):350–360.
  • Falck RS, Davis JC, Liu-Ambrose T. What is the association between sedentary behaviour and cognitive function? A systematic review. Br J Sports Med. 2017;51(10):800–811.
  • Cinzia G, Roberta P, Fabrizia L, et al. The effects of cognitive training for elderly: results from My Mind project. Rejuvenation Res. 2016;19(6):485–494.
  • Shao YK, Mang J, Li PL, et al. Computer-based cognitive programs for improvement of memory, processing speed and executive function during age-related cognitive decline: a meta-analysis. PLoS One. 2015;10(6):e0130831.
  • Antonelli Incalzi R, Corsonello A, Trojano L, et al. Cognitive training is ineffective in hypoxemic COPD: a six-month randomized controlled trial. Rejuvenation Res. 2008;11(1):239–250.
  • Szuhany KL, Bugatti M, Otto MW. A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res. 2015;60:56–64.
  • Chen HT, Chung YC, Chen YJ, et al. Effects of different types of exercise on body composition, muscle strength, and IGF-1 in the elderly with sarcopenic obesity. J Am Geriatr Soc. 2017;65(4):827–832.
  • Pasco JA, Williams LJ, Jacka FN, et al. Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function? Curr Osteoporos Rep. 2015;13(5):351–357.
  • Leal G, Afonso PM, Salazar IL, et al. Regulation of hippocampal synaptic plasticity by BDNF. Brain Res. 2015;1621:82–101.
  • Aquino G, Iuliano E, Di Cagno A, et al. Effects of combined training vs aerobic training on cognitive functions in COPD: a randomized controlled trial. Int J COPD. 2016;11:711–718.
  • Etnier JL, Berry M. Fluid intelligence in an older COPD sample after short- or long-term exercise. Med Sci Sports Exerc. 2001;33(10):1620–1628.
  • Mons U, Schottker B, Muller H, et al. History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol. 2013;28(10):823–831.
  • Martínez-Lapiscina EH, Clavero P, Toledo E, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurology, Neurosurg Psychiatry. 2013;84(12):1318–1325.
  • McEvoy CT, Guyer H, Langa KM, et al. Neuroprotective diets are associated with better cognitive function: the health and retirement study. J Am Geriatr Soc. 2017;65(8):1857–1862.
  • Tangney CC, Li H, Wang Y, et al. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology. 2014;83(16):1410–1416.
  • Gibson GE, Pulsinelli W, Blass JP, et al. Brain dysfunction in mild to moderate hypoxia. Am J Med. 1981;70(6):1247–1254.
  • Spencer SJ, Korosi A, Layé S, et al. Food for thought: how nutrition impacts cognition and emotion. npj Science of Food. 2017;1:7.
  • Roebuck-Spencer TM, Glen T, Puente AE, et al. Cognitive screening tests versus comprehensive neuropsychological test batteries: a National Academy of Neuropsychology education paper. Arch Clin Neuropsychol. 2017;32(4):491–498.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.